NYSE · Healthcare
ABTAbbott Laboratories
15-min delayed · via Finnhub
Loading chart…
Upcoming Earnings
Wednesday, January 20, 2027
After Close
In
81 days
EPS Estimate
$1.65
📊 Wall Street Consensus
32 analysts rating ABT
consensus
Data on Abbott Laboratories
Recent ABT News
Abbott Q3 Earnings Beat on Diagnostics and MedTech Recovery, 2026 Guidance Intact
Abbott Laboratories (ABT) beat Q3 2026 EPS estimates, driven by recovery in diagnostics and cardiovascular device segments
Oct 22, 2026
🇺🇸 United StatesAbbott Laboratories (ABT) Q2 Earnings Beat Drives 10%+ Share Surge
Abbott Q2 results broadly exceeded analyst estimates across multiple business segments, driving shares 10%+ in the market's strongest medtech response of the earnings season
Jul 17, 2026
🇺🇸 United StatesAbbott (ABT) Sees Significant Stock Surge of 12.5%
Abbott Laboratories (ABT) surged 12.5% in a major single-session rally reflecting strong Q2 earnings beat across diversified healthcare segments
Jul 17, 2026
About Abbott Laboratories
Similar Stocks
Data shown is informational only and may be delayed by up to 15 minutes. Not a recommendation to buy, sell, or hold any security. See our disclaimer.